Epigenetic editing is emerging as a promising alternative to conventional gene editing by precisely switching genes on or off without altering the underlying DNA sequence with the promise of offering safer, more broadly applicable therapies for a host of inherited and acquired chronic diseases, though serious pitfalls include inadvertent activation or silencing of nontarget genes—particularly those involved in tumor suppression, immunity, or development. | Khamsi, Nature News 2026
